Ranbaxy Recalls More Than 64,000 Bottles Of Generic Lipitor In U.S.

Ranbaxy Recalls More Than 64,000 Bottles Of Generic Lipitor In U.S.
The Ranbaxy Laboratories Ltd. logo is displayed on the side of a bottle of the company's Atorvastatin Calcium Tablets IP Storvas 10 tablets arranged for a photograph in Mumbai, India, on Thursday, Feb. 20, 2014. The U.S. is increasing scrutiny of generic drugs made in India, and in the past nine months banned imports from four plants belonging to Ranbaxy Laboratories Ltd. and Wockhardt Ltd. Photographer: Dhiraj Singh/Bloomberg via Getty Images
The Ranbaxy Laboratories Ltd. logo is displayed on the side of a bottle of the company's Atorvastatin Calcium Tablets IP Storvas 10 tablets arranged for a photograph in Mumbai, India, on Thursday, Feb. 20, 2014. The U.S. is increasing scrutiny of generic drugs made in India, and in the past nine months banned imports from four plants belonging to Ranbaxy Laboratories Ltd. and Wockhardt Ltd. Photographer: Dhiraj Singh/Bloomberg via Getty Images

Ranbaxy Laboratories Ltd., the India-based generic-drug maker beset by manufacturing-quality problems, has issued another recall of generic versions of the cholesterol drug Lipitor in the U.S. due to a potential dose mix-up.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE